52-week adjusted-price high
ActiveAdjusted close first reaches a 252-trading-day high; repeated hits within 20 days count once.
Free trial
Ask AI to review this stock
Copy the prompt to get recent events, historical reactions, and a short research brief.
Tell your AI:
Help me set up FinLab and analyze VTRS Viatris Inc.. Please read: https://finlab.finance/en/setup?stock=VTRS
VTRS
Viatris Inc. Healthcare As of 2026-07-31 Updated daily after market close
quality needs a look, discounted valuation.
2 active signals
This page refreshes daily after the close. Add Viatris Inc. to your watchlist to track signal changes on your next visit.
Is Viatris Inc. a buy? Fundamentals and valuation first
-
Quality is weaker than peers. Operating margin is only around the 38th percentile. TTM ROE is about -2.0%.
-
Valuation is cheaper than most peers. TTM P/E is in the 5th percentile, lower than most liquid US common stocks.
-
Recent volatility is moderate. 60-day annualized volatility is near the 34th percentile. Average 20-day dollar volume is about $158.8M.
-
Signals are active now. 52-week adjusted-price high, Top-quintile 6-month momentum currently holds; the tables below show what followed in this stock’s own history.
Historical evidence
Signals active now
Each active condition is tested against this stock’s own history and benchmarked versus the S&P 500.
Top-quintile 6-month momentum
Active · now 83.91489361702128%The stock ranks in the top 20% of the liquid US common-stock universe by 126-day adjusted return.
Average forward return after Top-quintile 6-month momentum。20-day: Win 50%, Sample 6, Median -0.71%, Excess -0.94%, Beat mkt rate 50%；60-day: Win 50%, Sample 6, Median -4.25%, Excess -6.75%, Beat mkt rate 16.7%；120-day: Win 16.7%, Sample 6, Median -10.62%, Excess -14.43%, Beat mkt rate 16.7%
120 days after: historical avg -6.75%
20-day +0.73%
60-day -7.96%
120-day -6.75%
20-day
60-day
120-day
Win
50%
50%
16.7%
Sample
6
6
6
Median
-0.71%
-4.25%
-10.62%
Excess
-0.94%
-6.75%
-14.43%
Beat mkt rate
50%
16.7%
16.7%
Over 6 occurrences, 120-day forward avg declined 6.75%, lagged the market by 14.43 pts; win rate 16.7%.
Valuation regime and forward returns
Daily TTM P/E is converted into an expanding own-history percentile, then grouped into five valuation regimes. Forward returns use adjusted prices over the next 240 trading days.
0-20 -0.3%
20-40 Insufficient data
40-60 -29.4%
60-80 -38.9%
80-100 -25.5% Now
| PE percentile band | Sample days | 240-day avg return | Median | Win rate | Avg excess (vs index) |
|---|---|---|---|---|---|
| 0-20 | 234 | -0.3% | -0.7% | 47.9% | -24% |
| 20-40 | 25 | Insufficient data | |||
| 40-60 | 90 | -29.4% | -27.6% | 0% | -42.2% |
| 60-80 | 62 | -38.9% | -39.9% | 0% | -46.2% |
| 80-100 You are here | 129 | -25.5% | -32% | 10.1% | -43.9% |
Quarterly EPS is aligned by SEC filing date before it is forward-filled to daily prices. The expanding percentile uses only information available up to each day.
Current TTM P/E is about 295.25, placing it in the 98.1 own-history percentile, inside the 80-100 bucket.
Valuation × momentum analogs
Each historical day is grouped by own-history P/E tercile and 60-day momentum direction, then tested for the next 120-trading-day adjusted return.
Momentum
Cheap (own-history bottom third)
Middle
Expensive (own-history top third)
60-day momentum up
-3.9%
165d
-33.1%
63d
-13.4%
91d
60-day momentum down
+7%
204d
-22.2%
69d
Now
+4.8%
68d
Currently in “Expensive (own-history top third) × 60-day momentum down”: across 68 historical days, 120-day forward avg gained 4.8%, win rate 63.2%, lagged the market by 0.9%.
Days = trading days in this bucket; returns use adjusted prices, ex-costs. 60-day momentum: direction of this stock's price over the past 60 trading days.
Market-wide momentum baseline
Across 97,878 liquid US common-stock samples, top-quintile 6-month momentum was followed by an average 60-trading-day return of +6.26%, a 58.3% positive-return rate, and +2.90 percentage points of average excess return versus the S&P 500.
Baseline: weekly samples since 2016 where a liquid US common stock ranked in the top quintile by 126-trading-day momentum. Forward return is 60 trading days; excess return is versus S&P 500 (^GSPC).
Signals not active now
Inactive signals still show the stock-specific historical forward-return distribution for context.
Filed revenue acceleration
PendingTTM revenue growth is at least 10% and improved versus the prior filed quarter; event date is the SEC filing date.
EPS surprise beat
PendingReported EPS beat consensus estimate by at least 5%; event date is the earnings-surprise timestamp.
19 times historically; 60-day forward avg +0.46%, win rate 44.4%, beating the market by -1.99 pts on average.
Method and limits
- Returns use us_price:adj_close, adjusted for splits and dividends where available.
- Excess returns use world_index:^GSPC as the S&P 500 benchmark proxy.
- Quarterly fundamentals are aligned to SEC filing dates before daily valuation studies.
- The promoted universe starts from active NYSE/NASDAQ common stocks, then applies price and dollar-volume gates.
- Snapshot-only tables such as analyst consensus, DCF, us_ratios, and us_key_metrics are intentionally excluded from historical evidence.
- Overlapping event windows are descriptive distributions, not independent samples.
This page is for historical data analysis and education only. It is not investment advice. Backtests and historical return distributions do not predict future performance; evaluate risk independently before trading.